NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market on Tuesday that revenues for the first quarter of its Fiscal Year 2014 grew 52 percent year over year, aided by publicity surrounding Angelina Jolie's use of the BRACAnalysis test.

The Salt Lake City-based company posted revenues of $202.5 million for the three months ended Sept. 30, up from $133.4 million a year ago, and topping the average analyst estimate of $167.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.